- 日
- 関
WordNet
- a writing implement with a point from which ink flows
- an enclosure for confining livestock
- female swan
PrepTutorEJDIC
- 〈C〉(インクを用いる筆記具全体をさして)『ペン』;万年筆,ポールペン,フェルトペン;ペン先 / 〈U〉《the~》文筆,著述 / 〈C〉《単数形で》《文》文筆家 / 《気どって》…‘を'書く,著す(write)
- 〈C〉(家畜などを入れる)『おり』 / 《集合的に》ありの中の動物 / 〈C〉(監禁・保護に使われる)囲い,幼児用遊びわく(playpen) / (囲い・ありなどに)…‘を'入れる,閉じ込める,監禁する《+『名』+[『up』]『in』+『名』》
- 刑務所[penitentiaryの短縮形]
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/06/01 08:10:07」(JST)
[Wiki en表示]
Faropenem, a penem. Note sulfur and double bond in ring.
Benzylpenicillin, a penam. Note the absence of the double bond in the ring. This is NOT a penEm
Imipenem, a carbapenem. Although imipenem has a sulfur, the sulfur is not in the ring.
A penem is a type of unsaturated β-lactam.
An example is faropenem.[1]
Penems are similar in structure to carbapenems. However, where penems have a sulfur, carbapenems have another carbon.[2]
There are no known naturally occurring penems; all of them are synthetically made.
Structure
See also: β-Lactam nomenclature
Penem molecules do not occur naturally, and production of penems is an entirely synthetic process.
Although structurally distinct, the penems are often confused with the carbapenem class of drugs.
Five main penem subgroups — thiopenems, oxypenems, aminopenems, alkylpenems, and arylpenems — have been produced and are distinguished by the side chain (at position 2) of the unsaturated five-membered ring. One structurally distinct penem is BRL 42715. This molecule has no substitution at the above position, but has a bulky group attached to the β-lactam ring, and it displays effective inhibition of class C β-lactamases, but no antimicrobial activity.
One possible consequence of these structural differences of penems from other β-lactams may be reduced immunogenicity and immunogenic cross-reactivity
References
- ^ Milazzo I, Blandino G, Caccamo F, Musumeci R, Nicoletti G, Speciale A (March 2003). "Faropenem, a new oral penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates". Journal of antimicrobial chemotherapy 51 (3): 721–5. doi:10.1093/jac/dkg120. PMID 12615878.
- ^ "Medscape.com".
Further reading
- Sasaki A, Goda K, Enomoto M, Sunagawa M (May 1992). "Synthetic studies of carbapenem and penem antibiotics. II. Synthesis of 3-acetyl-2-azetidinones by (2 + 2) cycloaddition of diketene and Schiff bases". Chemical & pharmaceutical bulletin 40 (5): 1094–7. doi:10.1248/cpb.40.1094. PMID 1394625.
Antibacterials: cell envelope antibiotics (J01C-J01D)
|
|
Intracellular |
- inhibit peptidoglycan subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin)
- DADAL/AR inhibitors (Cycloserine)
- bactoprenol inhibitors (Bacitracin)
|
|
Glycopeptide |
- inhibit PG chain elongation: Vancomycin# (Oritavancin
- Telavancin)
- Teicoplanin (Dalbavancin)
- Ramoplanin
|
|
β-lactams/
(inhibit PBP
cross-links) |
|
|
Other |
- polymyxins/detergent
- depolarizing
- hydrolyze NAM-NAG
- Gramicidin
- Isoniazid
- Teixobactin
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Index of bacterial disease
|
|
Description |
|
|
Disease |
- Gram-positive firmicutes
- Gram-positive actinobacteria
- Gram-negative proteobacteria
- Gram-negative non-proteobacteria
- Cholera
- Tuberculosis
|
|
Treatment |
- Antibiotics
- cell wall
- nucleic acid
- mycobacteria
- protein synthesis
- other
- Antibodies
- Vaccines
|
|
|
English Journal
- Incompatibility of ciprofloxacin and meropenem injections.
- Chen LY, Chen J, Waters V, Boodhan S.SourceDepartment of Pharmacylori.chen@sickkids.ca.
- American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.Am J Health Syst Pharm.2013 Nov 15;70(22):1966-70. doi: 10.2146/ajhp130339.
- PMID 24173004
- Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamases (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH).
- Lim CL, Lee W, Lee AL, Liew LT, Nah SC, Wan CN, Chlebicki MP, Kwa AL.AbstractBACKGROUND: Ertapenem (preferred choice for ESBL-producing organisms) use exhibited an increasing trend from 2006 to 2008. As extensive use of ertapenem might induce the mutation of resistant bacteria strains to ertapenem, we aimed to assess the appropriateness and impact of ertapenem-use, on ESBL production, the trends of gram-negative bacterial resistance and on the utilization of other antibiotics in our institution.
- BMC infectious diseases.BMC Infect Dis.2013 Nov 6;13(1):523. [Epub ahead of print]
- BACKGROUND: Ertapenem (preferred choice for ESBL-producing organisms) use exhibited an increasing trend from 2006 to 2008. As extensive use of ertapenem might induce the mutation of resistant bacteria strains to ertapenem, we aimed to assess the appropriateness and impact of ertapenem-use, on ESBL p
- PMID 24195651
- Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010.
- Vranić-Ladavac M, Bedenić B, Minandri F, Ištok M, Bošnjak Z, Frančula-Zaninović S, Ladavac R, Visca P.SourceCounty of Istria Public Health Institute, Nazorova 23, 52100, Pula, Croatia.
- European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.Eur J Clin Microbiol Infect Dis.2013 Nov 6. [Epub ahead of print]
- The molecular epidemiology and the genetic basis of carbapenem resistance was investigated in 185 Acinetobacter baumannii isolates obtained from 13 centers of northern Croatia and Istria during 2009-2010. All isolates were multidrug-resistant, and 35 % (n = 64) were resistant to both imipenem a
- PMID 24197438
Japanese Journal
- Regioselective ring expansion of 3,3-dimethylaziridin-2-carboxylate and a photochemical entry to the penem nucleus
- White James D.,Furuta Takuya
- Heterocycles 79(1), 347-352, 2009-04-01
- NAID 40016543067
- ハイリスク報告から推定される内科入院患者のMRSA検出危険度
- 島田 憲明,岡村 央,渡部 江津子,清水 彩加,三浦 邦久
- 環境感染 22(1), 23-27, 2007-03-30
- … In particular, patients who received penem or penicillin antibiotics tended to show high rates of MRSA infection. …
- NAID 10024358042
- Faropenem(ファロム錠【○!R】)の健常成人と感染症患者における母集団薬物動態解析
- 廣岡 秀樹,宗 政博,宮田 幸治,柴 孝也,谷川原 祐介
- 臨床薬理 = JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 36(4), 197-207, 2005-07-31
- … Faropenem (FRPM) is an oral penem antibacterial medicine with a high stability to beta-lactamase which has a broad antibacterial spectrum and a strong antibacterial activity to gram positive bacteria, and gram negative bacteria, except for <I>Pseudomonas aeruginosa</I> …
- NAID 10016651121
Related Links
- penem A β-lactam broad-spectrum antibiotic that acts on cell walls, lysing bacteria in resting phase; penicillins kill bacteria in growth phase by inhibiting ... The grounds upon which Linnaeus would fain have banished the whales from ...
- Penem is a medicine available in a number of countries worldwide. A list of US medications equivalent to Penem is available on the Drugs.com website. ... Drugs.com provides accurate and independent information on more than ...
Related Pictures
★リンクテーブル★
[★]
- 英
- penem antibiotic、penem
- 関
- ペネム
[★]
- 英
- penem
- 関
- ペネム系抗生物質
[★]
- 関
- penem
[★]
- 関
- lenapenem
[★]
- 関
- imipenem